| GTO ID | GTC1477 |
| Trial ID | NCT02107963 |
| Disease | Neuroblastoma | Melanoma | Osteosarcoma | Sarcoma |
| Altered gene | GD2 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GD2 CAR-T cells |
| Generation | 3rd |
| Phase | Phase1 |
| Recruitment status | Completed |
| Title | A Phase I Trial of T Cells Expressing an Anti-GD2 Chimeric Antigen Receptor in Children and Young Adults With GD2+ Solid Tumors |
| Year | 2014 |
| Country | United States |
| Company sponsor | National Cancer Institute (NCI) |
| Other ID(s) | 140059|14-C-0059 |
| Cohort 1 | |||||||||||
|
|||||||||||